Tokyo, June 11, 2025 – BIC Medical, the women’s health division of BIC GROUP, is proud to announce that Rosi, a groundbreaking pain management device designed exclusively for women, has received official regulatory approval in Japan. This marks a significant milestone in women’s health, as Rosi introduces a new standard in comfort and effective pain relief for women.
[Tokyo March 8th] BIC GROUP Announces Launch of bicmedstore.com: A Revolutionary B2B Ecommerce Platform Connecting Medical Healthcare Manufacturers and Healthcare Professionals Tokyo, Japan – BIC GROUP, a dynamic healthcare company dedicated to advancing the industry through innovation and excellence, proudly…
[Tokyo, Jan 16] – Today marks a significant milestone for BIC GROUP as it proudly launches bicjob.com, a revolutionary healthcare job board designed to reshape the landscape of talent acquisition in the industry. Pioneering Excellence in Healthcare Recruitment Since its…
The INDICAID™COVID-19 Antigen Test will be available for purchase starting September 8th. After much anticipation and hard work, we aredelighted to announce that the highly awaitedINDICAID™COVID-19 Antigen Test will beavailable for purchase starting September 8th!Mark your calendars for September 8th…
June 16, 2023 – INDICAID™ COVID-19 Rapid Antigen Test approved by Japan’s health ministry. The INDICAID COVID-19 Antigen Test is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein antigen from SARS-coV-2 indirect anterior nasal swab specimens…